Adagio Medical Holdings, Stock Today

ADGM Stock   0.78  0.01  0.64%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 80

 
High
 
Low
High
Adagio Medical is selling at 0.77499998 as of the 20th of January 2025; that is 0.64 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.75. Adagio Medical has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 26th of January 2024 and ending today, the 20th of January 2025. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
1st of August 2024
Category
Healthcare
Classification
Health Care
Adagio Medical is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 13.39 M outstanding shares of which 226.43 K shares are presently shorted by private and institutional investors with about 0.03 trading days to cover. More on Adagio Medical Holdings,

Moving together with Adagio Stock

  0.65GSK GlaxoSmithKline PLC ADR Sell-off TrendPairCorr
  0.74NVS Novartis AG ADRPairCorr

Moving against Adagio Stock

  0.59MBFJF Mitsubishi UFJ FinancialPairCorr
  0.42GILD Gilead SciencesPairCorr

Adagio Stock Highlights

CEO and PresidentidentOlav Bergheim
Business ConcentrationPharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Medical Devices, Health Care (View all Sectors)
Adagio Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Adagio Medical's financial leverage. It provides some insight into what part of Adagio Medical's total assets is financed by creditors.
Liquidity
Adagio Medical Holdings, currently holds 39.95 M in liabilities. Note, when we think about Adagio Medical's use of debt, we should always consider it together with its cash and equity.

Begin Period Cash Flow

4.74 Million
Adagio Medical Holdings, (ADGM) is traded on NASDAQ Exchange in USA. It is located in 26051 Merit Circle, Laguna Hills, CA, United States, 92653 and employs 87 people. Adagio Medical is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.65 M. Adagio Medical Holdings, conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 13.39 M outstanding shares of which 226.43 K shares are presently shorted by private and institutional investors with about 0.03 trading days to cover. Adagio Medical generates negative cash flow from operations
Check Adagio Medical Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Adagio Medical Holdings, is USD54.65 Million. Almost 72.02 percent of Adagio Medical outstanding shares are held by general public with 0.3 (percent) owned by insiders and only 27.68 % by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Adagio Ownership Details

Adagio Medical Historical Income Statement

At this time, Adagio Medical's Other Operating Expenses is very stable compared to the past year. As of the 20th of January 2025, Total Operating Expenses is likely to grow to about 32.5 M, while EBITDA is likely to drop (25.9 M). View More Fundamentals

Adagio Stock Against Markets

Adagio Medical Corporate Management

Tim GlynnVice SalesProfile
John DahldorfChief OfficerProfile
Nabil JubranChief OfficerProfile
Ilya GrigorovVice ManagementProfile
Alex BabkinChief OfficerProfile
Hakon BergheimChief OfficerProfile

Already Invested in Adagio Medical Holdings,?

The danger of trading Adagio Medical Holdings, is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Adagio Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Adagio Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Adagio Medical Holdings, is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Adagio Medical Holdings, is a strong investment it is important to analyze Adagio Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagio Medical's future performance. For an informed investment choice regarding Adagio Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adagio Medical Holdings,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagio Medical. If investors know Adagio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagio Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.76)
Revenue Per Share
0.348
Quarterly Revenue Growth
(0.57)
The market value of Adagio Medical Holdings, is measured differently than its book value, which is the value of Adagio that is recorded on the company's balance sheet. Investors also form their own opinion of Adagio Medical's value that differs from its market value or its book value, called intrinsic value, which is Adagio Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagio Medical's market value can be influenced by many factors that don't directly affect Adagio Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagio Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagio Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagio Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.